Developer docs
API playgroundTry for free, no card

Search company profiles

Gleam

Full company profile

uuid0007yxg

Namestring
Gleam
Legal namestring
Gleam Care, Inc.
Websiteurl
joingleam.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Gleam (legal entity: Gleam Care, Inc.) is a San Francisco-based healthcare technology company founded in 2023 that builds a browser-based AI assistant for clinical research site data entry. The product is a single unified SaaS tool delivered as a browser extension, designed to move data from any source document (browser-based eSource systems today, with paper and PDF support announced as forthcoming) into any Electronic Data Capture (EDC) system's Case Report Forms (CRFs). Its core workflow consists of four sequential steps: Learn (the system learns each CRF's structure and tracks protocol amendments), Fetch (it captures source data from eSource systems and flags uncertain fields), Fill (it auto-populates CRF fields with matched source data, supporting batch and one-click repeat use), and Trace (every EDC value can be clicked through to its source document, supporting quality control and audit readiness). The product is validated to 21 CFR Part 11 with a human-in-the-loop design: the system drafts and links values but a trained coordinator reviews and submits every entry, and the product is positioned outside the scope of FDA's January 2025 draft guidance on AI in regulatory decision-making. It works alongside existing eSource and EDC systems in the browser, requiring no installation, integrations, or sponsor approval to deploy.

The company contracts directly with clinical research sites rather than through sponsors or CROs, targeting independent sites, academic medical centers, hospital-based research sites, and site networks as a horizontal segment. Its go-to-market is sales-assisted: pricing is not publicly disclosed, and all customer acquisition flows through a demo request form on joingleam.com. Sponsors and CROs are referenced as a secondary segment served via compliance documentation rather than direct contracting. Distribution is direct (self-serve sign-up via app.joingleam.com or sales-assisted for enterprise), with content marketing through the Gleam Stream blog, podcast appearances (Note to File), and LinkedIn serving as the primary top-of-funnel channels. The company is founder-led by Oliver Keh (Founder & CEO), who previously founded Slope Clinical, and operates with a small team of 1-10 employees. It participated in Y Combinator in 2023 with backing from Liquid 2 Ventures and focal.

Short descriptiontext

Gleam builds a browser-based AI assistant that helps clinical research sites move data from source documents into EDC Case Report Forms with audit traceability, serving independent sites, academic medical centers, and site networks through a direct sales-assisted SaaS model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial software, EDC data entry, healthcare AI assistant, clinical research automation, 21 CFR Part 11
Industry1 code
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
Product category
Clinical Trial EDC Data Entry Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription (implied)
TypeSubscription Recurring
Description

Gleam operates as a browser-based SaaS tool accessed through app.joingleam.com. Pricing is not publicly disclosed; customers request a demo to get started, indicating a sales-assisted subscription model rather than self-serve pricing.

joingleam.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1No public pricing tiers available
ModelOtherBilling cadenceMonthly
Notes

Prospects complete a demo request form specifying their name, title/role, email, type of organization (Independent Site, Academic Medical Center/Hospital, Site Network, Sponsor, CRO, Other), and country. No pricing information is publicly available.

joingleam.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Gleam is a browser-based AI data-entry assistant for clinical research sites that reads source documents (eSource, with paper/PDF coming soon), drafts Electronic Data Capture (EDC) Case Report Form (CRF) entries, and provides a full audit trail linking every value back to its source. Delivered as a SaaS browser extension with a four-step Learn-Fetch-Fill-Trace workflow, it requires no integrations or sponsor approval and is validated to 21 CFR Part 11 with a human-in-the-loop design.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Site Director at Yuma Clinical Trials reports saving hours every week using Gleam
Product overview1 text field

Gleam is a single, unified SaaS product delivered as a browser extension. It is not a modular platform — all capabilities (Learn, Fetch, Fill, Trace) are built into one product designed specifically for clinical research sites. The workflow consists of four sequential steps: Learn (teaches the system CRF structure), Fetch (captures source data from eSource), Fill (auto-populates CRF fields), and Trace (shows source provenance for each entry). No installation, custom integrations, or sponsor approval is required. The product supports browser-based eSource and EDC systems, with paper/PDF source support announced as coming soon.

Product and service1 record
1Gleam
CategoryClinical Trial EDC Data Entry Software
Description

Browser-based AI data-entry assistant delivered as a SaaS tool and browser extension that learns EDC CRF structures, fetches source data from eSource systems, auto-fills EDC fields, and traces every entry back to its source document. Built exclusively for clinical research sites (independent sites, academic medical centers, hospital sites, and site networks), requires no integrations or sponsor approval, and is validated to 21 CFR Part 11 with human-in-the-loop review.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Florence builds workflow and eRegulatory/eSource tools specifically for clinical research sites, including document management and remote monitoring workflows. It addresses the same site-operations pain points Gleam targets and serves a similar buyer.

TypeDirect peer
Description

Castor offers a cloud-based EDC and ePRO platform widely adopted by independent clinical research sites and academic medical centers. It overlaps directly with Gleam's site-level data entry workflow, though it is an integrated EDC rather than a browser-extension assist layer.

3Mendel
TypeEmerging player
Description

Mendel applies AI/LLM technology to structure clinical trial data and operational workflows, including patient cohort and document understanding. It is an emerging AI-native competitor in adjacent clinical-trial data workflows.

TypeBroad incumbent
Description

Medidata Rave is one of the largest EDC platforms used by sponsors and CROs globally. As an incumbent with deep sponsor relationships and R&D scale, it represents the primary bundled-competition threat to standalone site tools like Gleam.

TypeBroad incumbent
Description

Medrio provides cloud-based EDC and eClinical solutions for sponsors, CROs, and sites, with a focus on Phase I–III trials. It competes in the same EDC and clinical data capture category Gleam addresses.

TypeDirect peer
Description

OpenClinica provides open-source and enterprise EDC platforms used by research sites, AMCs, and CROs. It competes in the same EDC data capture category where Gleam operates, particularly for cost-sensitive site networks.

TypeDirect peer
Description

RealTime Software Solutions offers CTMS, eRegulatory, and eSource/ePay tools specifically built for clinical research sites and site networks. It targets the same site-operations buyer with overlapping workflow functionality.

TypeBroad incumbent
Description

Veeva Vault EDC is a dominant sponsor-grade EDC platform in large pharma trials. It is a broader incumbent that could bundle AI-assisted entry features competitive to Gleam's workflow inside its sponsor-facing platform.

TypeDirect peer
Description

Prelude Dynamics provides the eClinicalOS EDC platform with strong penetration among independent sites and AMCs. It directly competes for the same site-level data capture buyer Gleam serves.

TypeBroad incumbent
Description

Advarra provides IRB, technology, and site-centric clinical trial services including eRegulatory and eSource platforms. It serves the same site ecosystem and could expand its technology portfolio to overlap with Gleam's offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gleam

Clinical Trial EDC Data Entry Softwarejoingleam.com

Gleam builds a browser-based AI assistant that helps clinical research sites move data from source documents into EDC Case Report Forms with audit traceability, serving independent sites, academic medical centers, and site networks through a direct sales-assisted SaaS model.

What Gleam does

Gleam (legal entity: Gleam Care, Inc.) is a San Francisco-based healthcare technology company founded in 2023 that builds a browser-based AI assistant for clinical research site data entry. The product is a single unified SaaS tool delivered as a browser extension, designed to move data from any source document (browser-based eSource systems today, with paper and PDF support announced as forthcoming) into any Electronic Data Capture (EDC) system's Case Report Forms (CRFs). Its core workflow consists of four sequential steps: Learn (the system learns each CRF's structure and tracks protocol amendments), Fetch (it captures source data from eSource systems and flags uncertain fields), Fill (it auto-populates CRF fields with matched source data, supporting batch and one-click repeat use), and Trace (every EDC value can be clicked through to its source document, supporting quality control and audit readiness). The product is validated to 21 CFR Part 11 with a human-in-the-loop design: the system drafts and links values but a trained coordinator reviews and submits every entry, and the product is positioned outside the scope of FDA's January 2025 draft guidance on AI in regulatory decision-making. It works alongside existing eSource and EDC systems in the browser, requiring no installation, integrations, or sponsor approval to deploy.

The company contracts directly with clinical research sites rather than through sponsors or CROs, targeting independent sites, academic medical centers, hospital-based research sites, and site networks as a horizontal segment. Its go-to-market is sales-assisted: pricing is not publicly disclosed, and all customer acquisition flows through a demo request form on joingleam.com. Sponsors and CROs are referenced as a secondary segment served via compliance documentation rather than direct contracting. Distribution is direct (self-serve sign-up via app.joingleam.com or sales-assisted for enterprise), with content marketing through the Gleam Stream blog, podcast appearances (Note to File), and LinkedIn serving as the primary top-of-funnel channels. The company is founder-led by Oliver Keh (Founder & CEO), who previously founded Slope Clinical, and operates with a small team of 1-10 employees. It participated in Y Combinator in 2023 with backing from Liquid 2 Ventures and focal.

Gleam firmographics

Firmographics
Name
Gleam
Legal name
Gleam Care, Inc.
Website
https://joingleam.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Gleam builds a browser-based AI assistant that helps clinical research sites move data from source documents into EDC Case Report Forms with audit traceability, serving independent sites, academic medical centers, and site networks through a direct sales-assisted SaaS model.
Ownership category
akta.pro rank

Gleam industry classification

Industry
Product category
Clinical Trial EDC Data Entry Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial software
  • EDC data entry
  • Healthcare AI assistant
  • Clinical research automation
  • 21 CFR Part 11

Where Gleam is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Gleam business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Subscription (implied): Gleam operates as a browser-based SaaS tool accessed through app.joingleam.com. Pricing is not publicly disclosed; customers request a demo to get started, indicating a sales-assisted subscription model rather than self-serve pricing.

Pricing tiers

ModelBillingPrice
OtherMonthlyNo public pricing tiers available

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Gleam product offering

Product offering

Core offering

Gleam is a browser-based AI data-entry assistant for clinical research sites that reads source documents (eSource, with paper/PDF coming soon), drafts Electronic Data Capture (EDC) Case Report Form (CRF) entries, and provides a full audit trail linking every value back to its source. Delivered as a SaaS browser extension with a four-step Learn-Fetch-Fill-Trace workflow, it requires no integrations or sponsor approval and is validated to 21 CFR Part 11 with a human-in-the-loop design.

Product overview

Gleam is a single, unified SaaS product delivered as a browser extension. It is not a modular platform — all capabilities (Learn, Fetch, Fill, Trace) are built into one product designed specifically for clinical research sites. The workflow consists of four sequential steps: Learn (teaches the system CRF structure), Fetch (captures source data from eSource), Fill (auto-populates CRF fields), and Trace (shows source provenance for each entry). No installation, custom integrations, or sponsor approval is required. The product supports browser-based eSource and EDC systems, with paper/PDF source support announced as coming soon.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gleam Browser-based AI data-entry assistant delivered as a SaaS tool and browser extension that learns EDC CRF structures, fetches source data from eSource systems, auto-fills EDC fields, and traces every entry back to its source document. Built exclusively for clinical research sites (independent sites, academic medical centers, hospital sites, and site networks), requires no integrations or sponsor approval, and is validated to 21 CFR Part 11 with human-in-the-loop review.

Quantifiable outcome

  • Site Director at Yuma Clinical Trials reports saving hours every week using Gleam

Companies that use Gleam

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Gleam technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Gleam partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights4 records

Gleam competitors and assessment

Company assessment

Direct peers

  • Florence Healthcare: Florence builds workflow and eRegulatory/eSource tools specifically for clinical research sites, including document management and remote monitoring workflows. It addresses the same site-operations pain points Gleam targets and serves a similar buyer.
  • Castor EDC: Castor offers a cloud-based EDC and ePRO platform widely adopted by independent clinical research sites and academic medical centers. It overlaps directly with Gleam's site-level data entry workflow, though it is an integrated EDC rather than a browser-extension assist layer.
  • OpenClinica: OpenClinica provides open-source and enterprise EDC platforms used by research sites, AMCs, and CROs. It competes in the same EDC data capture category where Gleam operates, particularly for cost-sensitive site networks.
  • RealTime Software Solutions: RealTime Software Solutions offers CTMS, eRegulatory, and eSource/ePay tools specifically built for clinical research sites and site networks. It targets the same site-operations buyer with overlapping workflow functionality.
  • Prelude Dynamics: Prelude Dynamics provides the eClinicalOS EDC platform with strong penetration among independent sites and AMCs. It directly competes for the same site-level data capture buyer Gleam serves.

Emerging players

  • Mendel: Mendel applies AI/LLM technology to structure clinical trial data and operational workflows, including patient cohort and document understanding. It is an emerging AI-native competitor in adjacent clinical-trial data workflows.

Broad incumbents

  • Medidata (Dassault Systèmes): Medidata Rave is one of the largest EDC platforms used by sponsors and CROs globally. As an incumbent with deep sponsor relationships and R&D scale, it represents the primary bundled-competition threat to standalone site tools like Gleam.
  • Medrio: Medrio provides cloud-based EDC and eClinical solutions for sponsors, CROs, and sites, with a focus on Phase I–III trials. It competes in the same EDC and clinical data capture category Gleam addresses.
  • Veeva Systems (Vault EDC): Veeva Vault EDC is a dominant sponsor-grade EDC platform in large pharma trials. It is a broader incumbent that could bundle AI-assisted entry features competitive to Gleam's workflow inside its sponsor-facing platform.
  • Advarra: Advarra provides IRB, technology, and site-centric clinical trial services including eRegulatory and eSource platforms. It serves the same site ecosystem and could expand its technology portfolio to overlap with Gleam's offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Gleam social profiles

Digital presence

Gleam compliance and trust

Trust signal

Compliance1 record

Gleam financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gleam leadership team

Management profile

Number of profiles

Profiles2 records

Gleam funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gleam M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gleam

What does Gleam do?

Gleam is a browser-based AI data-entry assistant for clinical research sites that reads source documents (eSource, with paper/PDF coming soon), drafts Electronic Data Capture (EDC) Case Report Form (CRF) entries, and provides a full audit trail linking every value back to its source. Delivered as a SaaS browser extension with a four-step Learn-Fetch-Fill-Trace workflow, it requires no integrations or sponsor approval and is validated to 21 CFR Part 11 with a human-in-the-loop design.

Is Gleam a public or private company?

Gleam is a private company. It is classified as venture growth investor backed and is currently operating.

When was Gleam founded?

Gleam was founded in 2023. It employs 11 to 50 people.

Where is Gleam based?

Gleam is headquartered in San Francisco, United States, in the North America region.

How does Gleam make money?

One revenue line is on record: saaS Subscription (implied).

Who are Gleam's main competitors?

Direct peers on record are Florence Healthcare, Castor EDC, OpenClinica, RealTime Software Solutions and Prelude Dynamics. Mendel is listed as an emerging player. Broad incumbents are Medidata (Dassault Systèmes), Medrio, Veeva Systems (Vault EDC) and Advarra.

Does Gleam have an API?

No public API is recorded for Gleam.

What industry is Gleam in?

Gleam's product category is Clinical Trial EDC Data Entry Software. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales